Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 471,176 | 356,082 | 366,967 | 540,919 | 757,049 |
| Marketable Securities | 447,942 | 251,011 | 343,714 | 300,020 | 148,126 |
| Receivables | 462 | N/A | 8,000 | N/A | N/A |
| TOTAL | $945,114 | $642,824 | $745,384 | $861,935 | $924,957 |
| Non-Current Assets | |||||
| PPE Net | 22,816 | 20,325 | 16,182 | 15,573 | 15,755 |
| Investments And Advances | 82,202 | 0 | 0 | 0 | 23,210 |
| Other Non-Current Assets | 43,176 | 40,439 | 26,127 | 27,719 | 25,877 |
| TOTAL | $148,194 | $60,764 | $42,309 | $43,292 | $64,842 |
| Total Assets | $1,093,308 | $703,588 | $787,693 | $905,227 | $989,799 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,646 | 1,458 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 10,340 | 8,945 | 9,839 | 12,835 | 13,086 |
| Accrued Expenses | 58,682 | 62,551 | 48,362 | 59,440 | 38,314 |
| Other current liabilities | N/A | 5,550 | 5,198 | 5,276 | 3,539 |
| TOTAL | $94,729 | $95,648 | $75,707 | $92,640 | $64,914 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,361,199 | 475,857 | 471,894 | 466,559 | 461,339 |
| Other Non-Current Liabilities | 34,748 | 40,871 | 38,587 | 35,602 | 26,760 |
| TOTAL | $1,387,944 | $501,684 | $496,173 | $486,981 | $475,867 |
| Total Liabilities | $1,482,673 | $597,332 | $571,880 | $579,621 | $540,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 149,284 | 148,956 | 122,568 | 122,362 | 121,370 |
| Common Shares | 152 | 125 | 125 | 125 | 124 |
| Retained earnings | -1,037,506 | -888,755 | -768,774 | -652,915 | -531,881 |
| Other shareholders' equity | 5,872 | 48,542 | 52,518 | 60,705 | 69,029 |
| TOTAL | $-389,365 | $106,256 | $215,813 | $325,606 | $449,018 |
| Total Liabilities And Equity | $1,093,308 | $703,588 | $787,693 | $905,227 | $989,799 |